239
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Effect of E-OJ-01 on Left Ventricular Ejection Fraction and Myocardial Oxygen Consumption: A Randomized, Double-Blind, Placebo-Controlled Study

ORCID Icon, ORCID Icon &
Pages 2511-2525 | Received 04 Jul 2022, Accepted 13 Sep 2022, Published online: 02 Nov 2022

References

  • Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021. doi:10.1016/j.jacc.2020.11.010
  • Nussbacher A, Gerstenblith G, O’Connor FC, et al. Hemodynamic effects of unloading the old heart. Am J Physiol. 1999;277(5):H1863–H1871. doi:10.1152/ajpheart
  • Arbab-Zadeh A, Dijk E, Prasad A, et al. Effect of aging and physical activity on left ventricular compliance. Circulation. 2004;110(13):1799–1805. doi:10.1161/01.CIR.0000142863.71285.74
  • Dwivedi S, Chopra D. Revisiting Terminalia arjuna - an ancient cardiovascular drug. J Tradit Complement Med. 2014;4(4):224–231. doi:10.4103/2225-4110.139103
  • Sikand G, Severson T. Top 10 dietary strategies for atherosclerotic cardiovascular risk reduction [published correction appears. Am J Prev Cardiol. 2020;4:100106. doi:10.1016/j.ajpc.2020.100106
  • Girandola RN, Srivastava S. Effect of E-OJ-01 on cardiac conditioning in young exercising adults: a randomized controlled trial. Am J Ther. 2017;24(3):e298–e307. doi:10.1097/MJT.0000000000000542
  • McCarty MF. Nutraceutical, dietary, and lifestyle options for prevention and treatment of ventricular hypertrophy and heart failure. Int J Mol Sci. 2021;22(7):3321. doi:10.3390/ijms22073321
  • Cicero AFG, Colletti A. Nutraceuticals and dietary supplements to improve quality of life and outcomes in heart failure patients. Curr Pharm Des. 2017;23(8):1265–1272. doi:10.2174/1381612823666170124120518
  • Wang C, Xiong B, Huang J. The role of omega-3 polyunsaturated fatty acids in heart failure: a meta-analysis of randomised controlled trials. Nutrients. 2016;9(1):18. doi:10.3390/nu9010018
  • Xin W, Wei W, Li X. Effects of fish oil supplementation on cardiac function in chronic heart failure: a meta-analysis of randomised controlled trials. Heart. 2012;98(22):1620–1625. doi:10.1136/heartjnl-2012-302119
  • Di Lorenzo A, Iannuzzo G, Parlato A, et al. Clinical EVidence for Q10 coenzyme supplementation in heart failure: from energetics to functional improvement. J Clin Med. 2020;9(5):1266. doi:10.3390/jcm9051266
  • Sharma A, Fonarow GC, Butler J, Ezekowitz JA, Felker GM. Coenzyme Q10 and heart failure: a state-of-the-art review. Circ Heart Fail. 2016;9(4):e002639. doi:10.1161/CIRCHEARTFAILURE.115.002639
  • Wu G, Meininger CJ. Arginine nutrition and cardiovascular function. J Nutr. 2000;130(11):2626–2629. doi:10.1093/jn/130.11.2626
  • Balderas-Munoz K, Castillo-Martínez L, Orea-Tejeda A, et al. Improvement of ventricular function in systolic heart failure patients with oral L-citrulline supplementation. Cardiol J. 2012;19(6):612–617. doi:10.5603/cj.2012.0113
  • Kato T, Kasai T, Sato A, et al. Effects of 3-month astaxanthin supplementation on cardiac function in heart failure patients with left ventricular systolic dysfunction-a pilot study. Nutrients. 2020;12(6):1896. doi:10.3390/nu12061896
  • Feringa HH, Laskey DA, Dickson JE, Coleman CI. The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials. J Am Diet Assoc. 2011;111(8):1173–1181. doi:10.1016/j.jada.2011.05.015
  • Pittler MH, Guo R, Ernst E. Hawthorn extract for treating chronic heart failure. Cochrane Database Syst Rev. 2008;(1):CD005312. doi:10.1002/14651858.CD005312.pub2
  • Ahluwalia A, Gladwin M, Coleman GD, et al. Dietary nitrate and the epidemiology of cardiovascular disease: report from a national heart, lung, and blood institute workshop. J Am Heart Assoc. 2016;5(7):e003402. doi:10.1161/JAHA.116.003402
  • Yu X, Huang L, Zhao J, et al. The relationship between serum zinc level and heart failure: a meta-analysis. Biomed Res Int. 2018;2018:2739014. doi:10.1155/2018/2739014
  • DiNicolantonio JJ, Mangan D, O’Keefe JH. Copper deficiency may be a leading cause of ischaemic heart disease. Open Heart. 2018;5(2):e000784. doi:10.1136/openhrt-2018-000784
  • Rosique-Esteban N, Guasch-Ferré M, Hernández-Alonso P, Salas-Salvadó J. Dietary magnesium and cardiovascular disease: a review with emphasis in epidemiological studies. Nutrients. 2018;10(2):168. doi:10.3390/nu10020168
  • Dwivedi S, Jauhari R. Beneficial effects of Terminalia arjuna in coronary artery disease. Indian Heart J. 1997;49(5):507–510.
  • Dwivedi S, Agarwal MP. Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease. J Assoc Physicians India. 1994;42(4):287–289.
  • Bhawani G, Kumar A, Murthy KS, Kumari N, Swami CG. A retrospective study of effect of Terminalia arjuna and evidence based standard therapy on echocardiographic parameters in patients of dilated cardiomyopathy. J Pharm Res. 2013;6(5):493–498. doi:10.1016/j.jopr.2013.05.006
  • Maulik SK, Wilson V, Seth S, et al. Clinical efficacy of water extract of stem bark of Terminalia arjuna (Roxb. ex DC.) Wight & Arn. in patients of chronic heart failure: a double-blind, randomized controlled trial. Phytomedicine. 2016;23(11):1211–1219. doi:10.1016/j.phymed.2016.02.007
  • Bharani A, Ganguli A, Mathur LK, Jamra Y, Raman PG. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate. Indian Heart J. 2002;54(2):170–175.
  • Dwivedi S, Chopra D, Bhandari B. Role of Terminalia arjuna Wight and Arn. in the treatment of chronic coronary artery disease from pharmacovigilance point of view. Ayu. 2019;40(2):104–108. doi:10.4103/ayu.AYU_114_18
  • Srivastava S, Girandola R, Kokate AS. Effect of Oxyjun™ on Adipose Tissue Inflammation-A Randomized, Placebo-Controlled Clinical Study. Int J Phys Educ Fit Sports. 2020;9(4):37–50. doi:10.34256/ijpefs2045
  • Mangion JR. M-Mode Imaging. Essential Echo. 2017;4:16.
  • Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension [published correction appears. Eur Heart J. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy339
  • American College of Cardiology. Symptom and activity level assessment (outpatient setting): heart failure - An ACC Clinical Toolkit. American College of Cardiology; 2014. Available from: https://www.acc.org/tools-and-practice-support/clinical-toolkits/~/media/1E4D8F9B69D14F55821BFE642FBFA221.ashx. Accessed October 4, 2022.
  • Mitter SS, Shah SJ, Thomas JD. A Test in Context: e/A and E/e’ to Assess Diastolic Dysfunction and LV Filling Pressure. J Am Coll Cardiol. 2017;69(11):1451–1464. doi:10.1016/j.jacc.2016.12.037
  • Kitzman DW, Sheikh KH, Beere PA, Philips JL, Higginbotham MB. Age-related alterations of Doppler left ventricular filling indexes in normal subjects are independent of left ventricular mass, heart rate, contractility and loading conditions. J Am Coll Cardiol. 1991;18(5):1243–1250. doi:10.1016/0735-1097(91)90542-h
  • Chenzbraun A, Keren A, Stern S. Doppler echocardiographic patterns of left ventricular filling in patients early after acute myocardial infarction. Am J Cardiol. 1992;70(7):711–714. doi:10.1016/0002-9149(92)90546-b
  • Nelson RR, Gobel FL, Jorgensen CR, Wang K, Wang Y, Taylor HL. Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulation. 1974;50:1179–1189. doi:10.1161/01.CIR.50.6.1179
  • Madhusudhan U. Effect of high and low intensities of aerobic training on rate pressure product. Natl J Physiol Pharm Pharmacol. 2018;8(4):550. doi:10.5455/njppp.2018.8.1145702122017
  • Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121–1123. doi:10.1001/archneur.1989.00520460115022
  • Jung CH, Yu JH, Bae SJ, et al. Serum gamma-glutamyltransferase is associated with arterial stiffness in healthy individuals. Clin Endocrinol (Oxf). 2011;75(3):328–334. doi:10.1111/j.1365-2265.2011.04060.x
  • Rohit S, Rahul M. Efficacy of heart failure reversal treatment in patients with low ejection fraction. J Ayurveda Integr Med. 2018;9(4):285–289. doi:10.1016/j.jaim.2017.08.004
  • DeVore AD, Hellkamp AS, Thomas L, et al. Improvement in left ventricular ejection fraction in outpatients with heart failure with reduced ejection fraction: data from CHAMP-HF. Circ Heart Fail. 2020;13(7):e006833. doi:10.1161/CIRCHEARTFAILURE.119.006833
  • Kramer DG, Trikalinos TA, Kent DM, Antonopoulos GV, Konstam MA, Udelson JE. Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach. J Am Coll Cardiol. 2010;56(5):392–406. doi:10.1016/j.jacc.2010.05.011
  • Liu SJ. Terminalia arjuna Bark and inotropic therapy for heart failure. CELLMED. 2012;2(3):21. doi:10.5667/tang.2012.0021
  • Kim YG, Park GM, Lee SB, et al. Association of gamma-glutamyl transferase with subclinical coronary atherosclerosis and cardiac outcomes in non-alcoholics. Sci Rep. 2020;10(1):17994. doi:10.1038/s41598-020-75078-6
  • Arinc H, Sarli B, Baktir AO, et al. Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis. Ups J Med Sci. 2013;118(4):228–234. doi:10.3109/03009734.2013.814734
  • Bhattacharjee B, Pal PK, Ghosh AK, Mishra S, Chattopadhyay A, Bandyopadhyay D. Aqueous bark extract of Terminalia arjuna protects against cadmium-induced hepatic and cardiac injuries in male Wistar rats through antioxidative mechanisms. Food Chem Toxicol. 2019;124:249–264. doi:10.1016/j.fct.2018.12.008
  • Hebbani AV, Vaddi DR, Dd PP, NCh V. Protective effect of Terminalia arjuna against alcohol induced oxidative damage of rat erythrocyte membranes. J Ayurveda Integr Med. 2021;12(2):330–339. doi:10.1016/j.jaim.2021.02.001
  • Kannappan SP, Raghunath G, Sivanesan S, Vijayaraghavan R, Swaminathan M. Antioxidant effect of Terminalia arjuna extract against acetaminophen-induced hepatotoxicity via the regulation of cytochrome P450 2E1, phosphatidylinositol-3-kinase/protein kinase B. Pharmacogn Mag. 2020;16(67):13. doi:10.4103/PM.PM_339_19
  • Pandey KB, Rizvi SI. Plant polyphenols as dietary anti-oxidants in human health and disease. Oxid Med Cell Longev. 2009;2(5):270–278. doi:10.4161/oxim.2.5.9498
  • Zhang H, Tsao R. Dietary polyphenols, oxidative stress and anti-oxidant and anti-inflammatory effects. Curr Opin Food Sci. 2016;8:33–42. doi:10.1016/J.COFS.2016.02.002
  • Varadharaj S, Kelly OJ, Khayat RN, Kumar PS, Ahmed N, Zweier JL. Role of dietary antioxidants in the preservation of vascular function and the modulation of health and disease. Front Cardiovasc Med. 2017;4:64. doi:10.3389/fcvm.2017.00064
  • Sandhu JS, Shah B, Shenoy S, Chauhan S, Lavekar GS, Padhi MM. Effects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adults. Int J Ayurveda Res. 2010;1(3):144–149. doi:10.4103/0974-7788.72485
  • Barbarawi M, Lakshman H, Barbarawi O, et al. Omega-3 supplementation and heart failure: a meta-analysis of 12 trials including 81,364 participants. Contemp Clin Trials. 2021;107:106458. doi:10.1016/j.cct.2021.106458
  • Lei L, Liu Y. Efficacy of Coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials. BMC Cardiovasc Disord. 2017;17:1. doi:10.1186/S12872-017-0628-9
  • Naghedi A, Haghaninejad H, Varastehravan H, Naghedi A, Farshadi N. Effect of vitamin D supplements on left ventricular ejection fraction in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials. Rev Port Cardiol. 2021;40(6):447–455. doi:10.1016/j.repce.2021.07.010
  • Bond V Jr, Curry BH, Adams RG, Millis RM, Haddad GE. Cardiorespiratory function associated with dietary nitrate supplementation. Appl Physiol Nutr Metab. 2014;39(2):168–172. doi:10.1139/apnm-2013-0263
  • Saunders B, Elliott-Sale K, Artioli GG, et al. β-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis. Br J Sports Med. 2017;51(8):658–669. doi:10.1136/bjsports-2016-096396
  • Alehagen U, Aaseth J, Alexander J, Johansson P. Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: a validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly. PLoS One. 2018;13(4):e0193120. doi:10.1371/journal.pone.0193120
  • Beulens JWJ, Dal Canto E, Stehouwer CDA, Rennenberg RJMW, Elders PJM, van Ballegooijen AJ. High vitamin K status is prospectively associated with decreased left ventricular mass in women: the Hoorn Study. Nutr J. 2021;20(1):85. doi:10.1186/s12937-021-00742-0
  • Khan MS, Khan F, Fonarow GC, et al. Dietary interventions and nutritional supplements for heart failure: a systematic appraisal and evidence map. Eur J Heart Fail. 2021;23(9):1468–1476. doi:10.1002/ejhf.2278
  • Song X, Qu H, Yang Z, Rong J, Cai W, Zhou H. Efficacy and safety of L-carnitine treatment for chronic heart failure: a meta-analysis of randomized controlled trials. Biomed Res Int. 2017;2017:6274854. doi:10.1155/2017/6274854
  • Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother. 2010;1(2):100107. doi:;1(2):100107. doi:10.4103/0976-500X.72352